MOTS-c keeps getting called an 'exercise mimetic,' and I want to pressure-test how much that label is earned versus a catchy summary.
The underlying biology is genuinely neat: it's a mitochondrial-derived peptide encoded in the 12S rRNA region, it translocates to the nucleus under metabolic stress, and it influences AMPK signaling and metabolic homeostasis. In mouse work it's been associated with improved insulin sensitivity and exercise capacity, which is where the 'mimetic' branding comes from.
My hesitation: most of the striking functional data is rodent, and 'affects the same pathway exercise does' is not the same as 'reproduces the benefits of exercise in humans.' Has anyone seen human data beyond observational/associative work on circulating MOTS-c levels? I'd like to calibrate how much weight the label deserves.